{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "20846035",
  "DateCompleted": {
    "Year": "2010",
    "Month": "10",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1086/655656"
    ],
    "Journal": {
      "ISSN": "1537-6613",
      "JournalIssue": {
        "Volume": "202 Suppl 2",
        "Issue": "Suppl 2",
        "PubDate": {
          "Year": "2010",
          "Month": "Oct",
          "Day": "15"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "HIV-1 transmission biology: selection and characteristics of infecting viruses.",
    "Pagination": {
      "StartPage": "S289",
      "EndPage": "S296",
      "MedlinePgn": "S289-96"
    },
    "Abstract": {
      "AbstractText": [
        "Individuals with recent human immunodeficiency virus type 1 (HIV-1) acquisition are likely to be a major source for other new infections because they have a high level of plasma virus, and the circulating virions possess unique properties that are highly suited for transmission. The acute infection period, however, presents a unique \"window of opportunity,\" because there are a limited number of genetic variants. Studies aim to elucidate the nature of the transmitted viruses and understand the mechanisms that inhibit the majority of variants present in the chronically infected partner from establishing a productive infection in the naive host. Greater understanding of these issues may open promising new ways to effectively block HIV-1 transmission."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02139, USA. msagar@partners.org"
          }
        ],
        "LastName": "Sagar",
        "ForeName": "Manish",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI077473",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI077473",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Variation"
    },
    {
      "QualifierName": [
        "transmission",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Haplorhini"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "transmission",
        "virology"
      ],
      "DescriptorName": "Simian Acquired Immunodeficiency Syndrome"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "Simian Immunodeficiency Virus"
    }
  ]
}